PAI Pharma Buys Nexus Pharmaceuticals, Adding 20-Plus Hospital Injectables
PAI Pharma acquired Nexus Pharmaceuticals, adding 20-plus hospital injectables to the Olympus Partners-backed buyer after its Nivagen deal built Sacramento manufacturing capacity.